ScitoVation specializes in facilitating pharmaceutical companies to efficiently identify potential toxicity of products on human cells. Extensive experience in data-rich technologies such as genomics, transcriptomics, high content imaging and high-throughput toxicology enable mechanistic understanding and precise predictions of pharmacokinetic and pharmacological responsiveness.
Common Problems We Solve
Toxicogenomic or Pharmacogenomic Studies
In vitro to in vivo extrapolation (IVIVE)
High Content Imaging
Cell Based Assays
Chemical Manufacturers and Consumer Products